PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27228464-5	2017	FGFR2, TWIST1, and FGFR3 mutations were identified in children with TCS.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	68-71	fibroblast growth factor receptor 2	Homo sapiens	0-5	
27228464-6	2017	All five children with a W290C mutation in FGFR2 had TCS, and most previously reported children with W290C had identification of TCS or early death.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	53-56	fibroblast growth factor receptor 2	Homo sapiens	43-48	
27228464-8	2017	CONCLUSION: There is an association between TCS and syndromic craniosynostosis, and it appears to be particularly high in individuals with the W290C mutation in FGFR2.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	44-47	fibroblast growth factor receptor 2	Homo sapiens	161-166	
34133757-2	2022	TCS is associated with syndromic craniosynostoses including Apert, Crouzon and Pfeiffer syndromes and FGFR2, FGFR3, and TWIST1 variants.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	0-3	fibroblast growth factor receptor 2	Homo sapiens	102-107	
34133757-17	2022	Genetic testing in patients with FGFR2-related syndromic craniosynostoses may identify those at risk of TCS and facilitate early intervention.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	104-107	fibroblast growth factor receptor 2	Homo sapiens	33-38